OHSU scientists discover new cause of Alzheimer’s, vascular dementia
WEBSep 5, 2023 · Researchers have discovered a new avenue of cell death in Alzheimer’s disease and vascular dementia. A new study, led by scientists at Oregon Health & Science University and published online in the journal Annals of Neurology on Aug. 21, reveals for the first time that a form of cell death known as ferroptosis — caused by a buildup of iron ...
Study Suggests Genetics as a Cause, Not Just a ... - The New York …
WEBMay 6, 2024 · A study suggests that genetics can be a cause of Alzheimer’s, not just a risk, raising the prospect of diagnosis years before symptoms appear. Determining whether someone has Alzheimer’s ...
Lecanemab in Early Alzheimer’s Disease | New England Journal of Medicine
WEBNov 29, 2022 · Lecanemab reduced markers of amyloid in early Alzheimer’s disease and resulted in moderately less decline on measures of cognition and function than placebo at 18 months but was associated with...
Lecanemab, the New Alzheimer’s Treatment: 3 Things To Know
WEBUpdated: July 24, 2023.] The Food and Drug Administration (FDA) recently granted full approval to a new Alzheimer’s treatment called lecanemab, which has been shown to moderately slow cognitive and functional decline in early-stage cases of the disease.
New drug donanemab is 'a turning point in the fight against …
WEBJul 17, 2023 · Full results about the Alzheimer's disease drug donanemab have been released today, supporting earlier trial results that suggested the breakthrough drug may slow down the progression of the disease. Dr Richard Oakley, Associate Director of Research and Innovation at Alzheimer’s Society, said:
FDA fully approves Leqembi, first drug shown to slow Alzheimer's ...
WEBJul 6, 2023 · In studies reviewed by the FDA, Leqembi appeared to slow declines in memory and thinking by about 27% after 18 months of treatment. It also dramatically reduced the sticky beta-amyloid plaques...
NIH releases 2022 dementia research progress report
WEBNovember 8, 2022. Alzheimer's Disease. NIH has released Advancing Alzheimer’s Disease and Related Dementias Research for All Populations: Prevent. Diagnose. Treat. Care. (PDF, 17M), a 2022 scientific progress report.
Start of new era for Alzheimer’s treatment — Harvard Gazette
WEBJune 5, 2023 9 min read. Expert discusses recent lecanemab trial, why it appears to offer hope for those with deadly disease. Researchers say we appear to be at the start of a new era for Alzheimer’s treatment.
Large-scale study of brain proteins uncovers new clues to …
WEBSep 29, 2022 · Through a large-scale analysis of tissue samples, NIA-funded researchers have discovered new disease-related changes in the brains of people who had died with Alzheimer’s disease. The study results, published in Nature Neuroscience, underscore the key role proteins may play in disease progression.
New insights into the genetic etiology of Alzheimer’s ... - Nature
WEBPublished: 04 April 2022. New insights into the genetic etiology of Alzheimer’s disease and related dementias. Céline Bellenguez, Fahri Küçükali, Iris E. Jansen, Luca Kleineidam, Sonia...
Skip to content